Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Forde

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Family Practice|February 3, 2007
Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profilesGrace Forde
The Journal of Family Practice|August 1, 2007
Practical management strategies for the chronic pain patientGrace Forde, Steven Stanos
The Medical Clinics of North America|November 29, 2015
Managing Chronic Headache DisordersGrace Forde, Robert A Duarte, Noah Rosen
Current Medical Research and Opinion|July 19, 2006
The impact of migraine on daily activities: effect of topiramate compared with placeboStephen D Silberstein, Elizabeth Loder, Grace Forde, et al.
Current Pain and Headache Reports|October 10, 2021
Medical Cannabis for Headache Pain: a Primer for CliniciansRobert A Duarte, Stephen Dahmer, Shayna Y Sanguinetti, et al.
The Journal of the American Osteopathic Association|August 8, 2007
Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraineFred G Freitag, Grace Forde, Walter Neto, et al.
Pain and Therapy|February 12, 2026
Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic IndicationsAndrew M Blumenfeld, Christopher Rhyne, Kenneth Martinez, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 23, 2025
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE studyGrace Forde, Kimberly Becker Ifantides, Angeli Mayadev, et al.
Toxins|October 25, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic IndicationGrace Forde, Benjamin M Brucker, Kimberly Becker Ifantides, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Family Practice|February 3, 2007
Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profilesGrace Forde
The Journal of Family Practice|August 1, 2007
Practical management strategies for the chronic pain patientGrace Forde, Steven Stanos
The Medical Clinics of North America|November 29, 2015
Managing Chronic Headache DisordersGrace Forde, Robert A Duarte, Noah Rosen
Current Medical Research and Opinion|July 19, 2006
The impact of migraine on daily activities: effect of topiramate compared with placeboStephen D Silberstein, Elizabeth Loder, Grace Forde, et al.
Current Pain and Headache Reports|October 10, 2021
Medical Cannabis for Headache Pain: a Primer for CliniciansRobert A Duarte, Stephen Dahmer, Shayna Y Sanguinetti, et al.
The Journal of the American Osteopathic Association|August 8, 2007
Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraineFred G Freitag, Grace Forde, Walter Neto, et al.
Pain and Therapy|February 12, 2026
Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic IndicationsAndrew M Blumenfeld, Christopher Rhyne, Kenneth Martinez, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 23, 2025
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE studyGrace Forde, Kimberly Becker Ifantides, Angeli Mayadev, et al.
Toxins|October 25, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic IndicationGrace Forde, Benjamin M Brucker, Kimberly Becker Ifantides, et al.
Pageof 1